Multiple myeloma (MM) is a type of cancer that affects plasma cells in the bone marrow, leading to various complications, including bone lesions and organ damage. Imaging techniques play a crucial ...

Imaging tests provide pictures of the tissues inside your body. These can help your healthcare team determine if you have multiple myeloma and how far it may have spread throughout your body. Imaging ...

A research team from the Heidelberg Medical Faculty, the German Cancer Research Center (DKFZ), the Berlin Institute of Health ...

During a Case-Based Roundtable® event, Muhammad Umair Mushtaq, MD, discussed managing long-term toxicity concerns related to ...

Researchers sought to identify prognostic factors for survival in patients with newly diagnosed multiple myeloma.

Black Americans have double the risk of developing multiple myeloma compared to white Americans and are diagnosed at younger ages.

Researchers sought to determine whether teclistamab would lead to a clinical response in patients with relapsed/refractory multiple myeloma.

The analysis of 11,427 Veterans Administration (VA) hospital patients with multiple myeloma (MM) reveals that lymphopenia affects 53% of patients at diagnosis. The median overall survival was 2.7 ...

In a retrospective study of 315 patients with relapsed/refractory multiple myeloma, retreatment with previously refractory drugs achieved an overall response rate of 56.2% and median progression ...

The phase 2 REST trial by Frida Bugge Askeland and colleagues, reported in The Lancet Haematology, provides insight into ...